Publikation

Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?

Wissenschaftlicher Artikel/Review - 06.05.2015

Bereiche
PubMed
DOI
Kontakt

Zitation
Grouzmann E, Fischli S, Henzen C, Zulewski H, Sigrist S, Drescher T, Brändle M, Bilz S, Matter M, Triponez F, Tschopp O, Abid K. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?. PloS one 2015; 10:e0125426.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
PloS one 2015; 10
Veröffentlichungsdatum
06.05.2015
eISSN (Online)
1932-6203
Seiten
e0125426
Kurzbeschreibung/Zielsetzung

Pheochromocytoma (PHEO) and paraganglioma (PGL) are catecholamine-producing neuroendocrine tumors that arise respectively inside or outside the adrenal medulla. Several reports have shown that adrenal glucocorticoids (GC) play an important regulatory role on the genes encoding the main enzymes involved in catecholamine (CAT) synthesis i.e. tyrosine hydroxylase (TH), dopamine β-hydroxylase (DBH) and phenylethanolamine N-methyltransferase (PNMT). To assess the influence of tumor location on CAT metabolism, 66 tissue samples (53 PHEO, 13 PGL) and 73 plasma samples (50 PHEO, 23 PGL) were studied. Western blot and qPCR were performed for TH, DBH and PNMT expression. We found a significantly lower intra-tumoral concentration of CAT and metanephrines (MNs) in PGL along with a downregulation of TH and PNMT at both mRNA and protein level compared with PHEO. However, when PHEO were partitioned into noradrenergic (NorAd) and mixed tumors based on an intra-tumoral CAT ratio (NE/E >90%), PGL and NorAd PHEO sustained similar TH, DBH and PNMT gene and protein expression. CAT concentration and composition were also similar between NorAd PHEO and PGL, excluding the use of CAT or MNs to discriminate between PGL and PHEO on the basis of biochemical tests. We observed an increase of TH mRNA concentration without correlation with TH protein expression in primary cell culture of PHEO and PGL incubated with dexamethasone during 24 hours; no changes were monitored for PNMT and DBH at both mRNA and protein level in PHEO and PGL. Altogether, these results indicate that long term CAT synthesis is not driven by the close environment where the tumor develops and suggest that GC alone is not sufficient to regulate CAT synthesis pathway in PHEO/PGL.